In the words of guest Mark Van Linden, “adversity can present itself to anybody at any time.” This episode features a personal narrative of life with a spinal cord injury. Dr. Karen Kelly-Blake, Associate Professor in the Center for Ethics and Humanities in the Life Sciences and the Department of Medicine at the Michigan State University College of Human Medicine, is joined by Mark Van Linden, MSA, and president of Adversity Solutions LLC. Mr. Van Linden experienced a spinal cord injury in 2009.
What would you do if you needed surgery, but seeking care would mean $25,000 or more in medical debt? Would you consider traveling to another country to receive the same surgery at a fraction of that cost? Would you put off seeking care entirely, until it became an emergency situation?
What can neuroscience tell us about human consciousness, the developing brains of babies, or lab-grown brain-like tissue? How do we define “consciousness” when it is a complex, much-debated topic? In this episode, Michigan State University researchers Dr. Laura Cabrera, Assistant Professor in the Center for Ethics and Humanities in the Life Sciences, and Dr.
This episode focuses on the topic of social determinants of health, or the social and environmental factors that influence our health and access to resources. How can social determinants of health be integrated effectively into medical education? Michigan State University Center for Ethics faculty members Libby Bogdan-Lovis and Dr.
We can look at an individual’s DNA and know what their hair color is, but what about their behavioral traits? This episode features Michigan State University faculty Dr. Laura Cabrera, Assistant Professor in the Center for Ethics and Humanities in the Life Sciences and the Department of Translational Neuroscience, and Dr. Mark Reimers, Associate Professor in the Neuroscience Program in the College of Natural Science.
What kinds of challenges currently exist within precision medicine? This episode focuses specifically on targeted cancer therapies, featuring a discussion between Center for Ethics Professor and Acting Director Dr. Len Fleck and Michigan State University College of Osteopathic Medicine student Stephanie Mackenzie. Dr. Fleck discusses ethics, economic, medical, and health policy issues related to these high-cost therapies. Additionally, he provides insight into how U.S.
How can shared decision-making tools and evidence-based guidelines be used to ensure that every patient receives the best care possible? How can patients be activated and equipped to interact with their provider and manage their health condition? In this episode, three Michigan State University researchers—Dr. Bill Hart-Davidson, Professor in the Department of Writing, Rhetoric, and American Cultures, Dr.
According to recent data from Donate Life America, more than 110,000 people are waiting for lifesaving organ transplants; 80% of those patients are waiting for a kidney. In this episode, Center Acting Director and Professor Dr. Leonard Fleck is joined by Dr. Arthur Ward of Michigan State University’s Lyman Briggs College. Dr.
What are the ethical implications of gene-editing human embryos? Do we risk stifling scientific advancement by banning such medical research? Guests Dr. Leonard Fleck, Acting Director and Professor in the Center for Ethics, and Dr. Marleen Eijkholt of Leiden University Medical Center in the Netherlands discuss the pros and cons, stemming from the recent news out of China of gene-edited babies.